Tonix Pharmaceuticals (TNXP) News Today $19.58 -0.42 (-2.10%) Closing price 04:00 PM EasternExtended Trading$19.70 +0.13 (+0.64%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest UpdateTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP - Get Free Report) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 1,120,000 shares, a growth of 21.8% from the March 31st total of 919,900 shares. Based on an average daily volume of 1,630,000 shares, the days-to-cover ratio is currently 0.7 days. Approximately 16.3% of the company's shares are short sold.May 5 at 3:17 PM | marketbeat.comTonix Pharmaceuticals Holding Corp Share Chat (TNXP.US)May 3 at 7:22 PM | lse.co.ukTonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual MeetingApril 29, 2025 | globenewswire.comTonix Pharmaceuticals present data on potential Mpox vaccine TNX-801April 26, 2025 | markets.businessinsider.comTonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025April 24, 2025 | globenewswire.comTonix Pharmaceuticals (TNXP) to Present at World Vaccine CongressApril 23, 2025 | gurufocus.comTonix Pharmaceuticals (TNXP) Falls Despite Market UpturnApril 23, 2025 | gurufocus.comTonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025April 16, 2025 | globenewswire.comTonix Pharmaceuticals, Makana to announce collaboration research agreementApril 9, 2025 | msn.comTonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix's Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana's Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation StudiesApril 9, 2025 | globenewswire.comWhat is Zacks Small Cap's Estimate for TNXP Q1 Earnings?Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP - Free Report) - Stock analysts at Zacks Small Cap issued their Q1 2025 earnings per share (EPS) estimates for shares of Tonix Pharmaceuticals in a report issued on Thursday, April 3rd. Zacks Small Cap analyst D. Bautz forecasts that the company wiApril 8, 2025 | marketbeat.comTonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on ...April 7, 2025 | gurufocus.comTonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual MeetingApril 7, 2025 | globenewswire.comBrokers Offer Predictions for TNXP Q1 EarningsTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP - Free Report) - Research analysts at Zacks Small Cap issued their Q1 2025 earnings estimates for Tonix Pharmaceuticals in a research report issued to clients and investors on Thursday, April 3rd. Zacks Small Cap analyst D. Bautz anticipates that tApril 7, 2025 | marketbeat.comWhat is Zacks Small Cap's Forecast for TNXP FY2027 Earnings?Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP - Free Report) - Equities researchers at Zacks Small Cap issued their FY2027 earnings per share (EPS) estimates for shares of Tonix Pharmaceuticals in a research note issued on Thursday, April 3rd. Zacks Small Cap analyst D. Bautz forecasts that thApril 5, 2025 | marketbeat.comTonix Pharmaceuticals (TNXP) Projected to Post Quarterly Earnings on MondayTonix Pharmaceuticals (NASDAQ:TNXP) will be releasing earnings before the market opens on Monday, April 7, Financial Modeling Prep reports.April 5, 2025 | marketbeat.comTNXP: No AdCom Required for TNX-102 SL NDA…April 3, 2025 | finance.yahoo.comTonix Pharmaceuticals launches TONIX ONE digital platformApril 2, 2025 | markets.businessinsider.comTonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation ConferenceApril 2, 2025 | globenewswire.comTonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine ConditionApril 1, 2025 | globenewswire.comTonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This YearMarch 31, 2025 | finance.yahoo.comWhat's Going On With Tonix Pharmaceuticals (TNXP) Stock?March 27, 2025 | benzinga.comTonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual MeetingMarch 27, 2025 | globenewswire.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 0.4% - Should You Sell?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 0.4% - Here's WhyMarch 26, 2025 | marketbeat.comTonix Pharmaceuticals Shares Jump After FDA Guidance for TNX-102March 26, 2025 | marketwatch.comTonix Pharmaceuticals: Potential To Have 'First' New Fibromyalgia Drug In 15 YearsMarch 26, 2025 | seekingalpha.comNoble Financial Sticks to Their Buy Rating for Tonix Pharma (TNXP)March 25, 2025 | markets.businessinsider.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 39.5% - Should You Buy?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 39.5% - Here's What HappenedMarch 25, 2025 | marketbeat.comTonix Pharmaceuticals: FDA AdCom News Positive, But Making Bull Case Is ProblematicMarch 25, 2025 | seekingalpha.comPharma Frenzy: Volatility Ignites Biotech Sector (TNXP)Two biotech companies have surged on recent developments, illustrating biotech's volatility and prompting investors to evaluate potential long-term value.March 25, 2025 | marketbeat.comTonix says FDA will not require committee meeting for TNX-102 SL NDAMarch 24, 2025 | markets.businessinsider.comTonix Pharmaceuticals stock soars on FDA updateMarch 24, 2025 | investing.comWhy Tonix Pharmaceuticals (TNXP) Stock Is RisingMarch 24, 2025 | benzinga.comTonix Pharma’s TNX-102 SL Advances in FDA ProcessMarch 24, 2025 | tipranks.comTonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of FibromyalgiaMarch 24, 2025 | globenewswire.comAs Mpox Cases Spread Around the World, Tonix Pharmaceuticals’ Single-Dose Vaccine TNX-801 Has Potential to Slow the SpreadMarch 20, 2025 | finance.yahoo.comAs Mpox Cases Spread Around the World, Tonix Pharmaceuticals' Single-Dose Vaccine TNX-801 Has ...March 20, 2025 | gurufocus.comAs Mpox Cases Spread Around The World, Tonix Pharmaceuticals' Single-Dose Vaccine TNX-801 Has Potential To Slow The SpreadMarch 20, 2025 | benzinga.comTonix Pharmaceuticals Shares Fall on Lower 4Q Revenue, Net LossMarch 19, 2025 | marketwatch.comTonix Pharma drops after Q4 revenue missMarch 19, 2025 | msn.comTonix Pharmaceuticals Stock Dives After Q4 Earnings Miss, But Retail’s Feeling BullishMarch 19, 2025 | msn.comAbsci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionMarch 19, 2025 | benzinga.comTonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational HighlightsMarch 19, 2025 | finanznachrichten.deTonix Pharmaceuticals reports Q4 EPS ($9.77) vs. ($2,179.83) last yearMarch 19, 2025 | markets.businessinsider.comTonix Pharmaceuticals Reports 2024 Financial Results and Pipeline ProgressMarch 18, 2025 | tipranks.comTonix Pharmaceuticals stock tumbles on earnings missMarch 18, 2025 | investing.comTonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and ...March 18, 2025 | gurufocus.comTonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational HighlightsMarch 18, 2025 | globenewswire.comTonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025March 13, 2025 | globenewswire.comTonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13thMarch 11, 2025 | gurufocus.com Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Email Address TNXP Media Mentions By Week TNXP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TNXP News Sentiment▼0.550.72▲Average Medical News Sentiment TNXP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TNXP Articles This Week▼44▲TNXP Articles Average Week Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Tourmaline Bio News Eton Pharmaceuticals News Rapport Therapeutics News PureTech Health News Mereo BioPharma Group News Zevra Therapeutics News Altimmune News Erasca News Sana Biotechnology News SNDL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TNXP) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tonix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TNXP Stock Free TNXP Stock Alerts